The owner of a patent on a brand-name drug sues a competitor for infringing the patent. The parties settle. But the infringer doesn't pay. The patent-owner does. Why? In return for the competitor's agreement not to compete during the rest of the patent's term.

Four of our 13 courts of appeals held that such a "reverse…